McDaniel Terry & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

McDaniel Terry & Co’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,336	Closed	-$373K	–	112
2021 Q4	$373K	Sell	3,336 -146	-4%	-$17.6K	0.04%	78
2021 Q3	$438K	Hold	3,482	–	–	0.05%	60
2021 Q2	$471K	Hold	3,482	–	–	0.05%	60
2021 Q1	$472K	Hold	3,482	–	–	0.06%	55
2020 Q4	$490K	Hold	3,482	–	–	0.06%	54
2020 Q3	$388K	Hold	3,482	–	–	0.05%	58
2020 Q2	$390K	Buy	+3,482	New	+$343K	0.06%	55

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

McDaniel Terry & Co's XBI Position: Q1 2022 in Review

McDaniel Terry & Co sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 3,336 shares — an estimated $373K sold.

McDaniel Terry & Co first reported a position in XBI in Q2 2020 and held it in 7 quarters. The position peaked at $490K in Q4 2020. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

McDaniel Terry & Co reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
McDaniel Terry & Co sold 3,336 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $373K.
McDaniel Terry & Co first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 7 quarters.
McDaniel Terry & Co's State Street SPDR S&P Biotech ETF position peaked at $490K in Q4 2020.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on McDaniel Terry & Co's 13F filing for Q1 2022, filed 27 Apr 2022.